1983 Oberlin College, BA
1989 Northwestern University, PhD - Physical Chemistry
2001 University of Virginia, School of Medicine, MD
2004-2007 Fellowship in Hematology/Oncology, Fletcher Allen Health Care, Burlington, VT
2001-2004 Resident, Internal Medicine, Fletcher Allen Healthcare, Burlington, VT
1991-1997 Post-doctoral Research particpant at the National Renewable Energy Laboratory, Center for Advanced Concept
1988-1991 Post-doctoral Northwestern University
2007 American Board of Internal Medicine Subspecialty in Hematology
2007 American Board of Internal Medicine Subspecialty in Medical Oncology
American Society of Hematology (ASH)
Americal Society of Clinical Oncology (ASCO)
American College of Physicians (ACP)
Sprague, JR and Wood ME. Statins and Breast Cancer Prevention: Time for Randomized Controlled Trials. J Clin Oncol 24: 2129-30, 2006.
Sprague JR and Wood ME. Breast Cancer Prevention: Time for Randomized Controlled Trials with Statins. Arch Intern Med 166:1143-44, 2006. Mori M, Sprague J. The successful remission induction by sorafenib and long-term complete remission in a FLT3-ITD-positive patient with a refractory acute erythroid leukemia and abnormal cytogenetics. Leukemia Research Epub October 2011
For a complete list of Julian Sprague's publications, please visit PubMed.